Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort Analysis

NCT05990959 · clinicaltrials.gov ↗
UNKNOWN
Status
800
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

China Medical University Hospital

Collaborators